Skip to main content

Table 4 Change from baseline to SVR 12 in patients with HCV genotype 1 infection

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

 

Baseline

SVR 12

p value

Platelets (10E3 μl-1)

171 ± 81

173 ± 76

0.8913

Total bilirubin (mg dl-1)

1.2 ± 1.0

0.7 ± 0.4

0.0052

INR

1.03 ± 0.12

1.06 ± 0.21

0.4964

Creatinine (mg dl-1)

0.77 ± 0.18

0.80 ± 0.17

0.5529

  1. Data are expressed as means ± SD
  2. SVR 12 sustained virological response at 12 weeks after end of treatment
  3. Boldface data statistically significant
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us